WHOLE SHINE MEDICAL(002622)

Search documents
皓宸医疗(002622) - 2014 Q1 - 季度财报
2014-04-25 16:00
Financial Performance - Revenue for Q1 2014 was CNY 19,913,111.35, a decrease of 29.6% compared to CNY 28,285,232.04 in the same period last year[10] - Net profit attributable to shareholders was CNY 4,086,092.52, down 14.92% from CNY 4,802,767.76 year-on-year[10] - Net cash flow from operating activities was negative CNY 8,140,315.37, a decline of 198.96% compared to positive CNY 8,226,278.46 in the previous year[10] - The net profit attributable to shareholders for the first half of 2014 is expected to decline by 48% to 21%, ranging from 10.348 million to 15.721 million yuan[22] - The net profit for the first half of 2013 was 19.90 million yuan, indicating a significant decrease in performance year-over-year[22] Assets and Equity - Total assets at the end of the reporting period were CNY 1,244,928,039.56, an increase of 0.23% from CNY 1,242,029,644.44 at the end of the previous year[10] - Net assets attributable to shareholders increased by 0.35% to CNY 1,180,341,072.51 from CNY 1,176,254,979.99 at the end of the previous year[10] Shareholder Information - The total number of shareholders at the end of the reporting period was 9,772[13] - The top shareholder, Lv Yongxiang, holds 33.66% of the shares, totaling 50,482,600 shares[13] - The company has made commitments to shareholders regarding the transfer and management of shares, ensuring stability in shareholding[21] Operational Insights - The company reported non-operating income of CNY 254,532.80 after tax adjustments[11] - The company is actively exploring new industry clients to mitigate the impact of deteriorating conditions in traditional industry clients[22] Investment Status - There are no securities investments reported during the period, with no shares held or changes in investment status[24] Earnings Per Share - Basic and diluted earnings per share remained unchanged at CNY 0.03[10] Return on Equity - The weighted average return on equity decreased to 0.35% from 0.42% year-on-year[10]
皓宸医疗(002622) - 2013 Q4 - 年度财报
2014-03-27 16:00
Financial Performance - The company's operating revenue for 2013 was CNY 184,680,609.77, a decrease of 24.52% compared to CNY 244,681,605.58 in 2012[25]. - The net profit attributable to shareholders for 2013 was CNY 38,671,545.51, down 28.95% from CNY 54,429,110.95 in the previous year[25]. - The net profit after deducting non-recurring gains and losses was CNY 36,410,499.09, a decline of 29.35% compared to CNY 51,538,812.01 in 2012[25]. - The basic earnings per share for 2013 was CNY 0.26, a decrease of 27.78% from CNY 0.36 in 2012[25]. - The total assets at the end of 2013 were CNY 1,242,029,644.44, reflecting a growth of 5.55% from CNY 1,176,674,529.89 at the end of 2012[25]. - The net assets attributable to shareholders increased by 3.4% to CNY 1,176,254,979.99 from CNY 1,137,583,434.48 in 2012[25]. - The weighted average return on equity for 2013 was 3.34%, down from 4.8% in 2012[25]. - The total profit for the period was 47.58 million yuan, with a net profit of 38.67 million yuan[43]. - The company achieved operating revenue of 184.68 million yuan, a year-on-year decrease of 24.52%[44]. - The company's operating costs amounted to CNY 98,149,076.50, reflecting a decrease of 24.63% year-on-year[69]. - The gross profit margin for the electrical switch industry was 58%, down by 2.65% from the previous year[69]. Cash Flow and Investments - The net cash flow from operating activities increased by 71.6% to CNY 69,323,576.06 from CNY 40,397,984.93 in 2012[25]. - The company reported a net increase in cash and cash equivalents of CNY 174,935,722.01, a significant turnaround from a decrease of CNY 97,455,600.02 in the previous year[64][67]. - Operating cash inflow decreased by 18.29% to CNY 259,515,780.63, primarily due to a reduction in contract amounts[64][65]. - The company has committed a total investment of CNY 30,059.18 million for various projects, with a cumulative investment of CNY 9,247.96 million, representing 30.73% of the planned investment progress[104]. - The company has utilized CNY 2,020 million of the raised funds to repay bank loans, achieving 100% of the intended use[104]. Research and Development - Research and development expenses increased by 2.94% to 14.43 million yuan, reflecting the company's commitment to innovation[44]. - The company is increasing its R&D investment and has several new products in the testing phase, aiming to improve product performance and innovation[40]. - The company is exploring new product development, particularly in the field of permanent magnet switches[138]. Market Strategy and Operations - The company is establishing a wholly-owned subsidiary in Beijing to serve as its marketing headquarters and R&D center, aiming to expand its marketing network nationwide and globally[41]. - The company has initiated a dual marketing strategy by maintaining its sales elite team while introducing an agent mechanism to improve market promotion effectiveness[42]. - The company has diversified its customer base, expanding into new industries such as power, railways, and real estate, which is expected to increase market share[79]. - The company plans to enhance its overall strength and broaden profit sources in 2014[114]. - The marketing strategy will involve tracking key customers and developing more industry-leading clients[116]. Dividend Policy - The company plans to distribute a cash dividend of CNY 0.26 per 10 shares to all shareholders[7]. - The cash dividend for 2013 represents 10.08% of the net profit attributable to shareholders, which is 38,671,545.51 yuan[130]. - The company has a policy to distribute at least 10% of the annual distributable profit in cash dividends, and the cumulative cash distribution over three consecutive years should not be less than 30% of the average annual distributable profit[132]. - The remaining undistributed profit for 2013 is 313,294,643.92 yuan, which will be carried forward to the next year[132]. Risk Management and Compliance - There are no significant risk factors adversely affecting the company's production, financial status, or ongoing profitability[14]. - The company has implemented internal audits to enhance management and risk control, improving operational efficiency and execution across various departments[41]. - The company has actively engaged in social responsibility initiatives, focusing on product safety, environmental protection, and community support[133]. - The company has not been subject to any administrative penalties during the reporting period[136]. - The company operates in an industry that is not classified as a heavily polluting industry by national environmental protection standards[134]. Shareholder Information - The total number of shares is 150,000,000, with 71.81% being restricted shares and 28.19% being unrestricted shares[190]. - The largest shareholder, Lv Yongxiang, holds 33.66% of the shares, amounting to 50,482,600 shares[199]. - The company has 12,243 shareholders at the end of the reporting period, an increase from 10,278 shareholders five trading days prior[199]. - The shareholding structure indicates that the top ten shareholders collectively hold 71.35% of the company's shares, with significant family ties among them[199].